AZN · story · 4 November
AstraZeneca · 3 headlines from 3 outlets, on 4 November 2026.
Naveen Krishna Yamarthi has been appointed managing director of AstraZeneca's India business and head of its Chennai centre.
The story's tone is the average of its headlines' own scores. Each score rates how good or bad the news was for the company, from −10 (clearly bad) to +10 (clearly good). 0 is neutral, and anything beyond ±6 is strong and rare. It rates the coverage, not the share price.
Average tone of each outlet's headlines in this story, −10 to +10. Impact = headlines × strength of tone.
DT Next is the largest at 1.7, ahead of BusinessLine (1.7).
Source: MarketFrame news analysis
| outlet | Average tone |
|---|---|
| DT Next | 1.7 |
| BusinessLine | 1.7 |
| BW People | 1.7 |
| Outlet | Headlines | Average tone |
|---|---|---|
| DT Next | 1 | +1.7 |
| BusinessLine | 1 | +1.7 |
| BW People | 1 | +1.7 |
One or two headlines is not a lean: read these as how this story was told, not as a verdict on the outlet.
| Tone | What the article reported, and why it scored that way |
|---|---|
| +1.7 | Routine leadership appointment at Indian unit and Chennai technology centre. |
| +1.7 | Routine Indian leadership appointment. |
| +1.7 | Routine leadership appointment in India. |
A short, free morning email on how the news treated AstraZeneca: the tone, the stories behind it, and when coverage starts to turn. Launching soon; one click to unsubscribe.